VIMPAT Infusion
Lacosamide
10mg/ml
UCB PHARMA S.A.
| Pack size | 20ml Glass Vial x 5 |
|---|---|
| Dispensing mode | POM |
| Source | BELGIUM |
| Agent | Modern Pharmaceutical Co. |
| Retail Price | 1140.50 AED |
Available as:
Indications
VIMPAT Infusion is used for:
Lacosamide is indicated for adjunctive therapy for partial onset seizures in patients with epilepsy over 17 years old. Injection is indicated for short term use when oral therapy is not feasible.
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Lacosamide :
Mechanism of Action
It is proposed that lacosamide's inhibition of sodium channels is responsible for analgesia. Lacosamide may be selective for inhibiting depolarized neurons rather than neurons with normal resting potentials. Pain and nociceptor hyperexcitability are associated with neural membrane depolarization. Lacosamide binds to collapsin response mediator protein-2 (CRMP-2), a phosphoprotein which is expressed primarily in the nervous system and is involved in neuronal differentiation and control of axonal outgrowth. The role CRMP-2 of binding in seizure control is hasn't been elucidated.
Note
VIMPAT 10mg/ml Infusion manufactured by UCB PHARMA S.A.. Its generic name is Lacosamide. VIMPAT is availble in United Arab Emirates.
Farmaco UAE drug index information on VIMPAT Infusion is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.